Nokia said Tuesday that it will buy Withings, a French company that makes a range of health- and fitness-centric wearables and connected gadgets for 170 million euros ($191 million), in an effort to jump into the consumer digital-health market. And while the move may sound like an odd one for the former cell-phone giant, it could turn out to be a smart bet.
Right now, the Finnish company is a shadow of its former self: once the biggest cell-phone maker in the world, it completed the sale of its phone business to Microsoft in 2014 and now runs just networking-equipment and research-and-development divisions (the latter of which works on licensing and new products, like the company’s OZO virtual-reality camera).
But Withings has been consistently lauded for clever, good-looking products like its smart watches, and its upcoming $100 Thermo smart thermometer even managed to impress this jaded journalist at January’s CES gadget show.
By snagging the company’s existing range of gadgets, which are in small but growing consumer-electronic niches—smart watches, activity trackers, smart scales, a smart alarm clock, and so on—Nokia gets a wide array of options for rolling out its own wearables and connected home devices in the future (and it’s already got the networking chops to make such things work well).
The acquisition also makes sense if Nokia is planning to get back into the smartphone game, which it has to hold off on until late this year because of an agreement with Microsoft. It could, for instance, come up with clever ways to make phones work with these gadgets in order to differentiate itself from competitors like Samsung and Apple.
Regardless of what its plans are, Nokia would be wise to keep in mind the cautionary tale of Cisco—the biggest maker of computer networking equipment, which tried for years to make its consumer business work until finally giving up in 2013. But since Nokia had so much success in the early years of the consumer cell-phone market, perhaps it can bounce back with a little help.
Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.
These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.
Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.
A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.